Clinical Trial Update: Safety and Efficacy of Vanoxerine for the Conversion of Subjects With Recent Onset Atrial Fibrillation or Flutter to Normal Sinus Rhythm [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating vanoxerine for converting recent-onset atrial fibrillation or flutter to normal sinus rhythm; the trial was terminated but results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Vanoxerine (vanoxerine)

Snippet

Sponsor: Laguna Pharmaceuticals, Inc. | Conditions: Atrial Fibrillation or Flutter | Phase 3 | Status: TERMINATED | Results posted: 2016-10-17